PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31560696 ↗2019Reported benefit

Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke.

RatIschaemia-reperfusionCerebral (MCAO/stroke)Sprague-Dawleymalen = Behaviour: n=26 NRG1-AdMSCs, n=18 AdMSCs, n=10 adenoviral N…Intracerebral stereotaxic injection into the left lateral striatum (0.7 mm anterior to bregma, 3.2 mm lateral, 5.5 mm below dura) over 5 min5 microlitres of AdMSC suspension in PBS; adenoviral NRG1 c…1 day after middle cerebral artery occlusion

Model: Transient focal cerebral ischaemia by intraluminal silicone-coated filament occlusion of the left middle cerebral artery for 60 min followed by reperfusion

NRG1-AdMSCs lowered modified Neurological Severity Scores and reduced infarct volume at 14 days compared with PBS, adenoviral NRG1 and naive AdMSCs, with higher exogenous and endogenous NRG1 and raised ErbB4, pMAPK and pAkt in the ischaemic hemisphere.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.